Literature DB >> 16959210

Cysteine 98 in CYP3A4 contributes to conformational integrity required for P450 interaction with CYP reductase.

Bo Wen1, Jed N Lampe, Arthur G Roberts, William M Atkins, A David Rodrigues, Sidney D Nelson.   

Abstract

Previously human cytochrome P450 3A4 was efficiently and specifically photolabeled by the photoaffinity ligand lapachenole. One of the modification sites was identified as cysteine 98 in the B-C loop region of the protein [B. Wen, C.E. Doneanu, C.A. Gartner, A.G. Roberts, W.M. Atkins, S.D. Nelson, Biochemistry 44 (2005) 1833-1845]. Loss of CO binding capacity and subsequent decrease of catalytic activity were observed in the labeled CYP3A4, which suggested that aromatic substitution on residue 98 triggered a critical conformational change and subsequent loss of enzyme activity. To test this hypothesis, C98A, C98S, C98F, and C98W mutants were generated by site-directed mutagenesis and expressed functionally as oligohistidine-tagged proteins. Unlike the mono-adduction observed in the wild-type protein, simultaneous multiple adductions occurred when C98F and C98W were photolabeled under the same conditions as the wild-type enzyme, indicating a substantial conformational change in these two mutants compared with the wild-type protein. Kinetic analysis revealed that the C98W mutant had a drastic 16-fold decrease in catalytic efficiency (V(max)/K(m)) for 1'-OH midazolam formation, and about an 8-fold decrease in catalytic efficiency (V(max)/K(m)) for 4-OH midazolam formation, while the C98A and C98S mutants retained the same enzyme activity as the wild-type enzyme. Photolabeling of C98A and C98S with lapachenole resulted in monoadduction of only Cys-468, in contrast to the labeling of Cys-98 in wild-type CYP3A4, demonstrating the marked selectivity of this photoaffinity ligand for cysteine residues. The slight increases in the midazolam binding constants (K(s)) in these mutants suggested negligible perturbation of the heme environment. Further activity studies using different P450:reductase ratios suggested that the affinity of P450 to reductase was significantly decreased in the C98W mutant, but not in the C98A and C98S mutants. In addition, the C98W mutant exhibited a 41% decrease in the maximum electron flow rate between P450 and reductase as measured by reduced nicotinamide adenine dinucleotide phosphate consumption at a saturating reductase concentration. In conclusion, our data strongly suggest that cysteine 98 in the B-C loop region significantly contributes to conformational integrity and catalytic activity of CYP3A4, and that this residue or residues nearby might be involved in an interaction with P450 reductase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959210      PMCID: PMC2001172          DOI: 10.1016/j.abb.2006.08.003

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  37 in total

1.  Elucidation of distinct ligand binding sites for cytochrome P450 3A4.

Authors:  N A Hosea; G P Miller; F P Guengerich
Journal:  Biochemistry       Date:  2000-05-23       Impact factor: 3.162

2.  Mechanism-based inactivation of cytochrome P450 2B1 by 7-ethynylcoumarin: verification of apo-P450 adduction by electrospray ion trap mass spectrometry.

Authors:  K A Regal; M L Schrag; U M Kent; L C Wienkers; P F Hollenberg
Journal:  Chem Res Toxicol       Date:  2000-04       Impact factor: 3.739

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The importance of SRS-1 residues in catalytic specificity of human cytochrome P450 3A4.

Authors:  F Roussel; K K Khan; J R Halpert
Journal:  Arch Biochem Biophys       Date:  2000-02-15       Impact factor: 4.013

5.  Mechanism-based inactivation of cytochrome P450 3A4 by L-754,394.

Authors:  L K Lightning; J P Jones; T Friedberg; M P Pritchard; M Shou; T H Rushmore; W F Trager
Journal:  Biochemistry       Date:  2000-04-18       Impact factor: 3.162

6.  Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.

Authors:  Pamela A Williams; Jose Cosme; Dijana Matak Vinkovic; Alison Ward; Hayley C Angove; Philip J Day; Clemens Vonrhein; Ian J Tickle; Harren Jhoti
Journal:  Science       Date:  2004-07-15       Impact factor: 47.728

7.  Role of itraconazole metabolites in CYP3A4 inhibition.

Authors:  Nina Isoherranen; Kent L Kunze; Kyle E Allen; Wendel L Nelson; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2004-07-08       Impact factor: 3.922

8.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

9.  Deuterium isotope effects in norcamphor metabolism by cytochrome P-450cam: kinetic evidence for the two-electron reduction of a high-valent iron-oxo intermediate.

Authors:  W M Atkins; S G Sligar
Journal:  Biochemistry       Date:  1988-03-08       Impact factor: 3.162

10.  The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution.

Authors:  Jason K Yano; Michael R Wester; Guillaume A Schoch; Keith J Griffin; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2004-07-16       Impact factor: 5.157

View more
  8 in total

1.  Site-specific fluorescent labeling and oriented immobilization of a triple mutant of CYP3A4 via C64.

Authors:  Amélie Ménard; Yue Huang; Pierre Karam; Gonzalo Cosa; Karine Auclair
Journal:  Bioconjug Chem       Date:  2012-04-02       Impact factor: 4.774

2.  High-Level Production and Properties of the Cysteine-Depleted Cytochrome P450 3A4.

Authors:  Irina F Sevrioukova
Journal:  Biochemistry       Date:  2017-06-07       Impact factor: 3.162

3.  Reaction of human cytochrome P450 3A4 with peroxynitrite: nitrotyrosine formation on the proximal side impairs its interaction with NADPH-cytochrome P450 reductase.

Authors:  Hsia-lien Lin; Cesar Kenaan; Haoming Zhang; Paul F Hollenberg
Journal:  Chem Res Toxicol       Date:  2012-10-16       Impact factor: 3.739

4.  Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b(5).

Authors:  Chunsheng Zhao; Qiuxia Gao; Arthur G Roberts; Scott A Shaffer; Catalin E Doneanu; Song Xue; David R Goodlett; Sidney D Nelson; William M Atkins
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

Review 5.  Advances in the Understanding of Protein-Protein Interactions in Drug Metabolizing Enzymes through the Use of Biophysical Techniques.

Authors:  Jed N Lampe
Journal:  Front Pharmacol       Date:  2017-08-08       Impact factor: 5.810

Review 6.  The current status of immunobased therapies for metastatic renal-cell carcinoma.

Authors:  Niranjan J Sathianathen; Suprita Krishna; J Kyle Anderson; Christopher J Weight; Shilpa Gupta; Badrinath R Konety; Thomas S Griffith
Journal:  Immunotargets Ther       Date:  2017-12-05

7.  Discovery and Visualization of Uncharacterized Drug-Protein Adducts Using Mass Spectrometry.

Authors:  Michael Riffle; Michael R Hoopmann; Daniel Jaschob; Guo Zhong; Robert L Moritz; Michael J MacCoss; Trisha N Davis; Nina Isoherranen; Alex Zelter
Journal:  Anal Chem       Date:  2022-02-20       Impact factor: 6.986

8.  Oxidation Protection in Metal-Binding Peptide Motif and Its Application to Antibody for Site-Selective Conjugation.

Authors:  Hye-Shin Chung; Sunbae Lee; Soon Jae Park
Journal:  PLoS One       Date:  2016-07-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.